World Allergy Organization Journal

Article	Citations
World Allergy Organization Anaphylaxis Guidance 2020	454
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee	111
COVID-19, asthma, and biological therapies: What we need to know	86
Managing food allergy: GA2LEN guideline 2022	59
Air pollution and indoor settings	58
Allergy and immunology in young children of Japan: The JECS cohort	56
Food protein-induced allergic proctocolitis in infants: Literature review and proposal of a management protocol	51
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence	48
Relationship between blood eosinophil levels and COVID-19 mortality	44
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities	38
The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources	38
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update	34
Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review	34
Acute asthma management during SARS-CoV2-pandemic 2020	33
A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia	33
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions	33
Update on latex allergy: New insights into an old problem	33
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers	32
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management	32
Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions	32
Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)	30
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)	30
A systematic review of infant feeding food allergy prevention guidelines – can we AGREE?	28
Food labeling issues for severe food allergic patients	27
An appraisal of allergic disorders in India and an urgent call for action	27

A new form of irritant rhinitis to filtering facepiece particle (FFP) masks (FFP2/N95/KN95 respirators) during COVID-19 pandemic	27
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement	26
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases	25
Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results	25
Anti-allergic and anti-inflammatory effects of resveratrol via inhibiting TXNIP-oxidative stress pathway in a mouse model of allergic rhinitis	24
Inborn errors of immunity with atopic phenotypes: A practical guide for allergists	23
Oral immunotherapy for peanut allergy: The pro argument	20
Does hereditary angioedema make COVID-19 worse?	20
A multicenter anaphylaxis registry in Korea: Clinical characteristics and acute treatment details from infants to older adults	19
Current and emerging biologic therapies targeting eosinophilic disorders	19
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement	18
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital	18
Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitis	18
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy	18
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both	18
Severe asthma: One disease and multiple definitions	17
Recent advances in the management of nut allergy	17
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments	17
The US population-level burden of cow's milk allergy	17
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients	16
An update on the prevalence, chronicity, and severity of atopic dermatitis and the associated epidemiological risk factors in the Singapore/Malaysia Chinese young adult population: A detailed descript	16
Psychological impact of the COVID-19 pandemic on patients with allergic diseases	16
Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review	16
Characteristics of pollen-related food allergy based on individual pollen allergy profiles in the Chinese population	16
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation	16
Food-dependent exercise-induced anaphylaxis to soybean: Gly m 5 and Gly m 6 as causative allergen components	16
Variability of grass pollen allergy symptoms throughout the season: Comparing symptom data profiles from the Patient's Hayfever Diary from 2014 to 2016 in Vienna (Austria)	16
The rationale for development of ligelizumab in food allergy	15
Evaluation of oral immunotherapy efficacy and safety by maintenance dose dependency: A multicenter randomized study	15
Biologics and global burden of asthma: A worldwide portrait and a call for action	15
Allergic diseases in infancy: I - Epidemiology and current interpretation	14
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients	14
Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts	14
Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use	13
DRESS syndrome: A literature review and treatment algorithm	13
Modern urbanization has reshaped the bacterial microbiome profiles of house dust in domestic environments	13
Dupilumab: An emerging therapy in allergic fungal rhinosinusitis	13
Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps	13
Pediatric usage of Omalizumab: A promising one	13
Prevalence of asthma and allergies among children in the United Arab Emirates: A cross-sectional study	13
Economic burden of severe asthma treatment: A real-life study	13
The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence	13
Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema	12
Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety	12
Comparison of individual-level and population-level risk factors for rhinoconjunctivitis, asthma, and eczema in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three	12
Risks and safety of biologics: A practical guide for allergists	12
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study	12
Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial	12
Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)	12
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective	12

The role of environmental allergen control in the management of asthma	12
Severity of COVID-19 in hospitalized patients with and without atopic disease	11
Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I	11
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	11
Association between maternal age at delivery and allergic rhinitis in schoolchildren: A population-based study	11
Parent perceptions in managing children with food allergy: An Australian perspective	11
Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: A cross-sectional study	11
Food allergies and allergens: Characterization and perceptions among diagnosed food allergic individuals in Lebanon	11
Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous urticaria - A real-life experience	11
Harmonizing allergy care–integrated care pathways and multidisciplinary approaches	11
Allergenicity assessment and allergen profile analysis of different Chinese wheat cultivars	10
Oral immunotherapy for food allergy: Translation from studies to clinical practice?	10
Prenatal vitamin D supplementation and child respiratory health: A systematic review and meta-analysis of randomized controlled trials	10
Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms	10
MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis	10
Factors that affect blood eosinophil counts in a non-asthmatic population: Post hoc analysis of data from Brazil	10
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group	10
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)	10
The spectrum of primary immunodeficiencies at a tertiary care hospital in Pakistan	10
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019	10
Effect of environmental exposures on allergen sensitization and the development of childhood allergic diseases: A large-scale population-based study	10
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study	10
Standardization of a colorimetric technique for determination of enzymatic activity of diamine oxidase (DAO) and its application in patients with clinical diagnosis of histamine intolerance	10
Expert consensus on the use of omalizumab in chronic urticaria in China	10
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's	9
Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform	9
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases	9
Prevalence of asthma symptoms and associated risk factors among adults in Saudi Arabia: A national survey from Global Asthma Network Phase Ⅰ	9
Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma	9
An updated prevalence of asthma, its phenotypes, and the identification of the potential asthma risk factors among young Chinese adults recruited in Singapore	9
Assessment of perception, attitude, and practice of primary care practitioners towards allergic rhinitis practice guidelines: Development and validation of a new questionnaire	9
Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis	9
Nasal IgE in subjects with allergic and non-allergic rhinitis	9
Utility of biomarkers in the diagnosis and monitoring of asthmatic children	9
Hydrolyzed rice formula for dietary management of infants with cow's milk allergy	9
Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study	9
The changes of clinical and histological characteristics of chronic rhinosinusitis in 18 years: Was there an inflammatory pattern shift in southern China?	8
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor	8
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)	8
Livestock farm particulate matter enhances airway inflammation in mice with or without allergic airway disease	8
The prevalence and temporal trends of food allergy among preschool children in Northern Thailand between 2010 and 2019	8
Atopic dermatitis in the COVID-19 era: Results from a web-based survey	8
Eosinophilic esophagitis in esophageal atresia: Tertiary care experience of a “selective” approach for biopsy sampling	8
Predicting allergic diseases in children using genome-wide association study (GWAS) data and family history	8
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19	8
Urban vs rural – Prevalence of self-reported allergies in various occupational and regional settings	8
Association of asthma comorbidity with poor prognosis of coronavirus disease 2019	8
Skin prick reactivity among asthmatics in East Africa	8
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review	7
Oral immunotherapy for peanut allergy: The con argument	7
Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine	7
IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma	7
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines update – VI – A quality appraisal with the AGREE II instrument	7
Knowledge of healthcare providers in the management of anaphylaxis	7
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics	7
WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways	7
Age-related differences in characteristics of anaphylaxis in Chinese children from infancy to adolescence	7
Prevalence of common sensitizing aeroallergens in Egyptian asthmatic patients	7
Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital	7
Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine	7
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis	7
Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets	7
Allergic rhinitis in Chinese young adults from the Singapore/Malaysia cross-sectional genetics epidemiology study (SMCGES) cohort: Prevalence, patterns, and epidemiology of allergic rhinitis	7
Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma	7
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic	7
Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status	7
Association of infant antibiotic exposure and risk of childhood asthma: A meta-analysis	7
Medical devices in allergy practice	7
Component-resolved diagnosis in adult patients with food-dependent anaphylaxis	7
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection	7
Allergic rhinitis aggravated by air pollutants in Latin America: A systematic review	7
Decreasing ten-year (2008–2018) trends of the prevalence of childhood asthma and air pollution in Southern Taiwan	7
Epidemiologic features and burden of atopic dermatitis in adolescent and adult patients: A cross-sectional multicenter study	6
Latin American anaphylaxis registry	6
WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19	6
Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life	6
Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions	6
Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)☆	6
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey	6
PEG allergy — A COVID-19 pandemic-made problem? A German perspective	6

Active smoking effect in allergic rhinitis	6
Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]	6
SARS-COV-2, can you be over it?	6
Efficacy of non-sedating H1-receptor antihistamines in adults and adolescents with chronic cough: A systematic review	6
Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controls	6
Clinical characteristics and management of iodine contrast media-related anaphylactic shock during cardiac catheterization	6
Linking cross-reactivity clusters of food and respiratory allergens in PAMD@ to asthma and duration of allergy	6
Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from t	6
The disease burden and quality of life of chronic cough patients in South Korea and Taiwan	6
Seafood graded oral food challenge outcomes in a pediatric tertiary care center	6
Dyslipidemia among allergic rhinitis patients: Frequency and risk factors	6
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy	6
Nasal polyps impact in severe asthma patients: evidences from the SANI	6
Beliefs and preferences regarding biological treatments for severe asthma	6
Lipid transfer protein syndrome: How to save a life through careful education	5
Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media	5
Impact of asthma control on different age groups in five Latin American countries	5
Cord blood 25(OH)D3, cord blood total immunoglobulin E levels, and food allergies in infancy: A birth cohort study in Chongqing, China	5
Safety of direct oral provocation testing using the Amoxicillin-2-step-challenge in children with history of non-immediate reactions to amoxicillin	5
Allergen Immunotherapy management during vaccinations: An international survey	5
Revisiting differences between atopic and non-atopic asthmatics: When age is shaping airway inflammatory profile	5
The food allergy COPE inventory: Adaptation and psychometric properties	5
Smoking behavior might affect allergic rhinitis and vasomotor rhinitis differently: A mendelian randomization appraisal	5
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic	5
High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs	5
Omalizumab is effective in nasal polyposis with or without asthma, a real-life study	5
Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis	5
Prevalence of skin diseases in children 1 to 6 years old in the city of Bogota, Colombia	5
Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update	5
The role of allergen-specific IgE in predicting allergic symptoms on dog and cat exposure among Korean pet exhibition participants	5
The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity	5
CircRNA expression profiles and circRNA-miRNA-mRNA crosstalk in allergic rhinitis	5
Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting S	5
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy	5
Skin manifestations in pediatric patients with primary immunodeficiency diseases (PIDs) in a tertiary care hospital in Colombia	5
Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A r	5
Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care	5
Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study	5
Identification of an immunodominant IgE epitope of Der p 39, a novel allergen of Dermatophagoides pteronyssinus	5
Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I	5
75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results	5
Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose – a single center experience	5
Allergy education and training for physicians	5
Digital tools in allergy and respiratory care	5
Identifying gene network patterns and associated cellular immune responses in children with or without nut allergy	5
Effects of respiratory short-chain fatty acids on bronchial inflammation in asthma	5
Impact of COVID-19 pandemic on asthma symptoms and management: A prospective analysis of asthmatic children in Ecuador	5
Prevalence and clinical features of adverse food reactions in Portuguese adolescents	5
Multi-omics profiling approach in food allergy	5
Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines	5